OPKO Health (NASDAQ: OPK) reported Q2 EPS of ($0.19), $0.08 worse than the analyst estimate of ($0.11). Revenue for the quarter came in at $156.8 million versus the consensus estimate of $165.7 million.

For earnings history and earnings-related data on OPKO Health (OPK) click here.